AU3524995A - Method for treatment of cancers by regulating the activity of ras proteins - Google Patents

Method for treatment of cancers by regulating the activity of ras proteins

Info

Publication number
AU3524995A
AU3524995A AU35249/95A AU3524995A AU3524995A AU 3524995 A AU3524995 A AU 3524995A AU 35249/95 A AU35249/95 A AU 35249/95A AU 3524995 A AU3524995 A AU 3524995A AU 3524995 A AU3524995 A AU 3524995A
Authority
AU
Australia
Prior art keywords
cancers
regulating
activity
treatment
ras proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU35249/95A
Inventor
Bruno Tocque
Bohdan Wasylik
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Sante et de la Recherche Medicale INSERM
Aventis Pharma SA
Original Assignee
Rhone Poulenc Rorer SA
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer SA, Institut National de la Sante et de la Recherche Medicale INSERM filed Critical Rhone Poulenc Rorer SA
Publication of AU3524995A publication Critical patent/AU3524995A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
AU35249/95A 1994-09-27 1995-09-22 Method for treatment of cancers by regulating the activity of ras proteins Abandoned AU3524995A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9411510A FR2724846B1 (en) 1994-09-27 1994-09-27 METHOD OF TREATING CANCER BY REGULATING THE ACTIVITY OF RAS PROTEINS
FR9411510 1994-09-27
PCT/FR1995/001227 WO1996010087A1 (en) 1994-09-27 1995-09-22 Method for treatment of cancers by regulating the activity of ras proteins

Publications (1)

Publication Number Publication Date
AU3524995A true AU3524995A (en) 1996-04-19

Family

ID=9467309

Family Applications (1)

Application Number Title Priority Date Filing Date
AU35249/95A Abandoned AU3524995A (en) 1994-09-27 1995-09-22 Method for treatment of cancers by regulating the activity of ras proteins

Country Status (3)

Country Link
AU (1) AU3524995A (en)
FR (1) FR2724846B1 (en)
WO (1) WO1996010087A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6465253B1 (en) 1994-09-08 2002-10-15 Genvec, Inc. Vectors and methods for gene transfer to cells
US5846782A (en) * 1995-11-28 1998-12-08 Genvec, Inc. Targeting adenovirus with use of constrained peptide motifs
US5770442A (en) * 1995-02-21 1998-06-23 Cornell Research Foundation, Inc. Chimeric adenoviral fiber protein and methods of using same
US6127525A (en) * 1995-02-21 2000-10-03 Cornell Research Foundation, Inc. Chimeric adenoviral coat protein and methods of using same
US6248351B1 (en) 1997-01-10 2001-06-19 Board Of Regents,The University Of Texas System Human PEA3 is a tumor suppressor for cancer cells
US20030017138A1 (en) 1998-07-08 2003-01-23 Menzo Havenga Chimeric adenoviruses
US6929946B1 (en) 1998-11-20 2005-08-16 Crucell Holland B.V. Gene delivery vectors provided with a tissue tropism for smooth muscle cells, and/or endothelial cells
US6492169B1 (en) 1999-05-18 2002-12-10 Crucell Holland, B.V. Complementing cell lines
US6913922B1 (en) 1999-05-18 2005-07-05 Crucell Holland B.V. Serotype of adenovirus and uses thereof
EP1330271A4 (en) * 2000-09-20 2005-11-09 Beth Israel Hospital Use of transcription factors for treating inflammation and other diseases
US7235233B2 (en) 2000-09-26 2007-06-26 Crucell Holland B.V. Serotype 5 adenoviral vectors with chimeric fibers for gene delivery in skeletal muscle cells or myoblasts
US20050260582A1 (en) * 2001-02-13 2005-11-24 Hirofumi Kai Cell proliferation inhibitors comprising ets transcription factor or gene encoding the same
NZ534866A (en) 2002-04-25 2007-04-27 Crucell Holland B Means and methods for the production of adenovirus vectors

Also Published As

Publication number Publication date
FR2724846B1 (en) 1996-12-20
FR2724846A1 (en) 1996-03-29
WO1996010087A1 (en) 1996-04-04

Similar Documents

Publication Publication Date Title
AU5750796A (en) System for the treatment of insomnia
AU6112896A (en) Tyrphostin-like compounds for the treatment of cell prolifer ative disorders or cell differentiation disorders
AU6124996A (en) Certain arylsulfonamido-substituted hydroxamic acids for the treatment of certain tumors
ZA966240B (en) Methods for treatment of allergic asthma.
AU7689791A (en) Drug-free method for treatment of alopecia
AU4958096A (en) Process for the treatment of gases
AU5268696A (en) Novel compounds and methods for therapy
AU4918796A (en) Methods of treating or preventing psychiatric disorders
AU3548795A (en) Benzopyranopyrazolyl derivatives for the treatment of inflammation
HUP9900422A3 (en) Novel protein and methods for the production of the same
AU4880197A (en) Method for treatment of dermatological disorders
AU7905894A (en) Treatment of poultry
AU1935395A (en) Method for treating conditions of the eye using polypeptides
AU2103295A (en) Methods for the treatment of thrombosis
AU6222096A (en) Phenoxy piperazine derivatives for treating disorders of the dopamine system
AU4524889A (en) Method for the treatment of periodontal disease
AU3524995A (en) Method for treatment of cancers by regulating the activity of ras proteins
AU3974189A (en) Process for the catalytic treatment of wastewater
AU3133889A (en) Method for the treatment of the extraphyramidal side effects associated with neuroleptic therapy
AU4090289A (en) Method for the treatment of wool
AU5175796A (en) Method of identifying molecules that regulate fgf activity
AU7310896A (en) Use of nitroflavonoids for the treatment of anxiety
AU3187595A (en) Compounds for the treatment of restenosis
AU5198898A (en) Method for treatment of glutamate related disorders
AU6927894A (en) 4-amidinophenylsulphonamides for the treatment of thrombo-embolitic conditions